MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Anpec (New Formulation) | |
New | B. Braun 0.9% Sodium Chloride Injection | |
New | Braltus | |
New | Cresemba | |
New | Dexmedetomidine Mylan | |
New | Estrogel Pro | |
New | Glycophos | |
New | Kanjinti | |
New | Lamotrigine ARW | |
New | Medsurge Hydromorphone, HP | |
New | Mevadol Forte | |
New | Moxifloxacin APO | |
New | Olanzapine APOTEX | |
New | Rizatriptan ODT APOTEX | |
New | Surgilube | |
New | Teriflagio | |
New | Verzenio | |
Reinstated | Monopril | |
Revised | Abyraz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | ADT Booster | Dose and Method of Administration |
Revised | Aminoven 10% | TGA Date |
Revised | APO-Amisulpride | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Indapamide SR | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Oxazepam | TGA Date |
Revised | APO-Prochlorperazine | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | APO-Rizatriptan | TGA Date |
Revised | APO-Telmisartan HCTZ | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APO-Temazepam | List of Excipients, Pharmaceutical Form |
Revised | APOTEX-Pioglitazone | Special Warnings and Precautions for Use |
Revised | APO-Tramadol/Paracetamol | Special Warnings and Precautions for Use |
Revised | APO-Venlafaxine XR | Adverse Effects (Undesirable Effects) |
Revised | Asasantin SR | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Aspen Ciprofloxacin Injection for Intravenous Infusion | Special Warnings and Precautions for Use |
Revised | Atazanavir Mylan | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | Atenolol-AFT | TGA Date |
Revised | Atripla | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Atrovent Metered Aerosol (CFC-free) | Dose and Method of Administration, List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Atrovent Nebulising Solution | Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Aubagio | Adverse Effects (Undesirable Effects) |
Revised | Belsomra | Adverse Effects (Undesirable Effects) |
Revised | Blooms the Chemist Venlafaxine XR | Adverse Effects (Undesirable Effects) |
Revised | Brenzys | Adverse Effects (Undesirable Effects) |
Revised | Brimica Genuair 340/12 | TGA Date |
Revised | Cardol | TGA Date |
Revised | Cardol 80 mg | TGA Date |
Revised | Cefepime Kabi | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Special Warnings and Precautions for Use |
Revised | Ceftriaxone Alphapharm | Nature and Contents of Container |
Revised | Cephazolin Alphapharm | Nature and Contents of Container |
Revised | Ceprotin | List of Excipients, Nature and Contents of Container, Poisons Schedule, Qualitative and Quantitative Composition, Shelf Life |
Revised | Ciprofloxacin GH | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Sponsor |
Revised | Cisatracurium-AFT | TGA Date |
Revised | ClinOleic 20% | Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Clomid | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Indications, List of Excipients, Pharmaceutical Form, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Cytotec | Special Precautions for Storage, TGA Date |
Revised | DBL Remifentanil | TGA Date |
Revised | DBL Vincristine Sulfate Injection | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Warnings and Precautions for Use |
Revised | Diclofenac Sandoz | Special Warnings and Precautions for Use |
Revised | Diflucan | TGA Date |
Revised | Duratocin | Adverse Effects (Undesirable Effects) |
Revised | Dymista 125/50 | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Eviplera | Adverse Effects (Undesirable Effects) |
Revised | Exelon Patch | Nature and Contents of Container |
Revised | Ezovir | List of Excipients, Special Warnings and Precautions for Use |
Revised | Femolet | TGA Date |
Revised | Flutamin | TGA Date |
Revised | Fragmin | Pharmaceutical Form, Physicochemical Properties |
Revised | Furosemide-Baxter | Product Name change, Special Precautions for Storage, Sponsor |
Revised | Genvoya | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Glamin | TGA Date |
Revised | Glucose Intravenous Infusion BP 5% (Pfizer) | Description |
Revised | Glyxambi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Hospira Levetiracetam Concentrate for IV Infusion | TGA Date |
Revised | Hypnovel | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Imovane | Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Special Warnings and Precautions for Use |
Revised | Irbesartan GH | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use, Storage |
Revised | Irbesartan/HCT Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Jadenu | Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use |
Revised | Jinarc | Boxed Warnings, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Konakion | TGA Date |
Revised | Konakion MM Paediatric | TGA Date |
Revised | Kuvan | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Lenest 20 ED | List of Excipients |
Revised | Lenest 30 ED | TGA Date |
Revised | Loette | Pharmaceutical Form |
Revised | Lonsurf | Adverse Effects (Undesirable Effects), New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Magicul | Nature and Contents of Container |
Revised | Mavenclad | Special Precautions for Storage |
Revised | Maviret | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Maxalt | TGA Date |
Revised | Meropenem APOTEX | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Minidiab | TGA Date |
Revised | Mobic | Dose and Method of Administration, Nature and Contents of Container |
Revised | Modafin | Contraindications, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Monofeme | TGA Date |
Revised | Myozyme | TGA Date |
Revised | Nexium Hp7 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Nordette | Pharmaceutical Form |
Revised | Normison | List of Excipients, Pharmaceutical Form |
Revised | Novacodone | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nucala | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Palexia IR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Palexia SR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Shelf Life, Special Warnings and Precautions for Use |
Revised | Penthrox Inhalation | Dose and Method of Administration |
Revised | Persantin SR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Pfizer (Perth) Carboplatin | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Product Name change, Special Warnings and Precautions for Use |
Revised | Pfizer (Perth) Leucovorin Calcium Injection | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pharmacor Amlodipine | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Shelf Life |
Revised | Piax | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Plaquenil | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Predsolone | Product Name change |
Revised | Pregabalin GH | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Quetiapine Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Rabipur | Dose and Method of Administration, List of Excipients, Nature and Contents of Container |
Revised | Renflexis | Adverse Effects (Undesirable Effects) |
Revised | Resprim, Resprim Forte | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Rexulti | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Rizatriptan Wafers-10 mg | List of Excipients, Product Name change |
Revised | Roximycin | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Simplotan | TGA Date |
Revised | Sodium Valproate Wockhardt | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Solaraze | Product Name change, Special Precautions for Storage |
Revised | Sulprix | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tafinlar | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Targin | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Tarka | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Temozolomide Alphapharm | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tobramycin Injection | Special Warnings and Precautions for Use |
Revised | Tramadol Sandoz Injection | TGA Date |
Revised | Tramedo | Dosage and Administration, List of Excipients, Name of Medicine, Nature and Contents of Container, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use, Sponsor |
Revised | Trifeme | List of Excipients, Pharmaceutical Form |
Revised | Triphasil | TGA Date |
Revised | Venclexta | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Viagra | Nature and Contents of Container |
Revised | Visanne | Special Precautions for Storage, TGA Date |
Revised | Zetin | Special Warnings and Precautions for Use |
Revised | Zinopril | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Zofran | Deleted Presentation, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Name of Medicine, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Zydol | Special Warnings and Precautions for Use |
Revised | Zydol SR | Special Warnings and Precautions for Use |
Deleted | Alendronate AN | |
Deleted | APO-Amoxycillin and Clavulanic Acid 500/125 | |
Deleted | Atorvastatin Sandoz | |
Deleted | Bisoprolol AN | |
Deleted | Cephalexin AN | |
Deleted | Clopidogrel Amneal | |
Deleted | Cyprone | |
Deleted | Diclofenac Amneal | |
Deleted | Donepezil AN | |
Deleted | Duro-K | |
Deleted | Exaccord | |
Deleted | Finasta | |
Deleted | Fluconazole Alphapharm | |
Deleted | Fludarabine AN | |
Deleted | FluQuadri and FluQuadri Junior | |
Deleted | Galantamine AN SR | |
Deleted | Gemzar | |
Deleted | Indapamide AN SR | |
Deleted | Irbesartan HCT Winthrop | |
Deleted | Irbesartan HCTZ Amneal | |
Deleted | Irbesartan Winthrop | |
Deleted | Irbesatzide GH | |
Deleted | KSART HCT | |
Deleted | Lamotrigine AN | |
Deleted | Levitaccord | |
Deleted | Lisinopril AN | |
Deleted | Lovir | |
Deleted | Meloxiauro | |
Deleted | Meloxicam AN | |
Deleted | Metoclopramide AN | |
Deleted | Moxiclav Duo, Moxiclav Duo Forte | |
Deleted | Olanzapine AN | |
Deleted | Olanzapine AN ODT | |
Deleted | Olmesartan AN | |
Deleted | Olmesartan HCT AN | |
Deleted | Oncaspar | |
Deleted | Panalgesic | |
Deleted | Pharmacor Amisulpride | |
Deleted | Pharmacor Diclofenac 50 | |
Deleted | Pizaccord | |
Deleted | Rancef | |
Deleted | Robitussin Chesty Cough | |
Deleted | Roxithromycin GH | |
Deleted | Slow-K | |
Deleted | Telmisartan HCTZ AN | |
Deleted | Terbinafine AN | |
Deleted | Terbinafine GH | |
Deleted | Topiramate AN | |
Deleted | Venlafaxine AN SR |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au